Loading...

Pro Medicus Limited

PMCUFPNK
HealthcareMedical - Healthcare Information Services
$176.00
$0.23(0.13%)

Pro Medicus Limited (PMCUF) Stock Overview

Explore Pro Medicus Limited’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
29.30%
29.30%
Profit Growth
$0.79
36.52%
EPS Growth
$0.79
36.21%
Operating Margin
70.29%
33.75%
ROE
47.73%
36.52%
Dividend Yield
0.00%
39.96%
Analyst Recommendations data is not available for PMCUFAnalyst Recommendations details for PMCUF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

CEO

Dr. Sam Aaron Hupert M.B.B.S., M.D.

Employees

75

Headquarters

450 Swan Street, Richmond, VIC

Founded

2021

Frequently Asked Questions